↓ Skip to main content

Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam

Overview of attention for article published in Epilepsia, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
3 news outlets
twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam
Published in
Epilepsia, August 2012
DOI 10.1111/j.1528-1167.2012.03603.x
Pubmed ID
Authors

Christoph Helmstaedter, Yoan Mihov, Mohammad R. Toliat, Holger Thiele, Peter Nuernberg, Susanne Schoch, Rainer Surges, Christian E. Elger, Wolfram S. Kunz, René Hurlemann

Abstract

Levetiracetam (LEV) is a highly effective antiepileptic agent. A clinically relevant psychiatric complication of LEV treatment, however, is the provocation of irritability and aggression. Recent behavioral research indicates that personality traits may predispose to these side effects. To assess the genetic basis of the adverse psychotropic profile of LEV, a candidate gene-based two-stage association study was conducted.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ethiopia 1 1%
France 1 1%
United Kingdom 1 1%
Japan 1 1%
United States 1 1%
Unknown 88 95%

Demographic breakdown

Readers by professional status Count As %
Other 11 12%
Researcher 10 11%
Student > Ph. D. Student 9 10%
Professor > Associate Professor 9 10%
Student > Master 8 9%
Other 24 26%
Unknown 22 24%
Readers by discipline Count As %
Medicine and Dentistry 30 32%
Neuroscience 11 12%
Biochemistry, Genetics and Molecular Biology 7 8%
Agricultural and Biological Sciences 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Other 9 10%
Unknown 24 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2022.
All research outputs
#1,439,941
of 24,712,008 outputs
Outputs from Epilepsia
#342
of 5,723 outputs
Outputs of similar age
#8,180
of 171,627 outputs
Outputs of similar age from Epilepsia
#1
of 67 outputs
Altmetric has tracked 24,712,008 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,723 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,627 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.